Barclays’s Cumberland Pharmaceuticals CPIX Stock Holding History

Barclays’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$311	Buy	+48	New	+$230	﹤0.01%	5063
2025 Q3	–	Sell	-2	Closed	-$7	–	5523
2025 Q2	$7	Buy	+2	New	+$9	﹤0.01%	5161
2020 Q3	–	Sell	-22	Closed	–	–	5261
2020 Q2	$0	Buy	+22	New	+$80	﹤0.01%	5653
2020 Q1	–	Sell	-3	Closed	–	–	6175
2019 Q4	$0	Sell	3 -82	-96%	-$433	﹤0.01%	6401
2019 Q3	$1K	Buy	+85	New	+$473	﹤0.01%	6579
2013 Q3	–	Sell	-10,761	Closed	-$55K	–	7429
2013 Q2	$55K	Buy	+10,761	New	+$53.5K	﹤0.01%	6243

Other funds holding CPIX

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Barclays's CPIX Position: Q2 2026 in Review

Barclays opened a new position in Cumberland Pharmaceuticals (CPIX) in Q2 2026: 48 shares worth $311. The stake represents ﹤0.01% of the portfolio and ranks #5063 among its holdings. This is a return to the name: Barclays previously reported a position in CPIX as recently as Q2 2025.

Barclays first reported a position in CPIX in Q2 2013 and has held it in 6 quarters since. The position peaked at $55K in Q2 2013. 32 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

Barclays held 48 shares of Cumberland Pharmaceuticals worth $311 as of Q2 2026.
Cumberland Pharmaceuticals was a new Barclays position in Q2 2026.
Cumberland Pharmaceuticals made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #5063 holding.
Barclays first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 6 quarters since.
Barclays's Cumberland Pharmaceuticals position peaked at $55K in Q2 2013.
32 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.